Indications for Lenalidomide

Lenalidomide (Lenalidomide) is a drug widely used to treat a variety of malignant hematological diseases and immune system-related diseases. Its indications mainly include the following aspects:

1.Multiple Myeloma (Multiple Myeloma): Lenalidomide is widely used in the treatment of multiple myeloma. Multiple myeloma is a malignant blood disease that typically manifests as an abnormal proliferation of plasma cells in the bone marrow, leading to bone destruction, anemia and other symptoms. Lenalidomide is often used in combination with drugs such as dexamethasone in patients with newly diagnosed multiple myeloma and in patients whose disease has relapsed or progressed after first-line therapy.

2.High-risk myelodysplastic syndrome (MDS): Lenalidomide can also be used to treat high-risk MDS patients, helping to improve hematopoietic function and reduce anemia symptoms. MDSare a group of bone marrow disorders in which the bone marrow does not produce healthy blood cells properly.

3.Anemia-related conditions: Lenalidomide may also be considered in some conditions where the anemia is related to immune system abnormalities or bone marrow problems. This includes some specific types of anemia in which abnormal activity of the immune system may play a role.

In summary, lenalidomide has demonstrated significant efficacy in the treatment of hematological malignancies such as multiple myeloma and high-risk myelodysplastic syndromes. It helps improve patients' survival rate, reduce disease symptoms, and improve quality of life through mechanisms such as immune system regulation, inhibiting tumor cell proliferation, and improving hematopoietic function. However, the use of lenalidomide needs to be under physician supervision and managed individually based on the patient's specific condition and treatment response to ensure optimal treatment results.

Lenalidomide has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is around 3,500~4,000 yuan. Due to different medical insurance policies in various places, the price also varies. Please consult your local pharmacy for specific prices. There are also original research drugs in China, but the price is as high as tens of thousands of yuan, so it is not recommended to buy them. The cheaper ones abroad are mainly generic drugs, including those from India, Bangladesh, and Laos, which cost about a few hundred yuan per box. The ingredients of foreign generic drugs and domestic lenalidomide drugs are basically the same.